Clinical Trials Successful


Auckland, New Zealand - Intradermal injection of a purified cell wall component from heat-killed Mycobacterium vaccae may one day be used to treat children with severe atopic dermatitis, if a clinical program carried out by a New Zealand company continues to be successful.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.